e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Bronchiectasis and respiratory infections caused by Pseudomonas
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Air flow obstruction is associated with
Pseudomonas
in non-CF bronchiectasis patients
S. Zaidi, K. Khan, R. Behan, E. Moloney, S. Lane (Dublin, Ireland)
Source:
Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Session:
Bronchiectasis and respiratory infections caused by Pseudomonas
Session type:
Thematic Poster Session
Number:
2904
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Zaidi, K. Khan, R. Behan, E. Moloney, S. Lane (Dublin, Ireland). Air flow obstruction is associated with
Pseudomonas
in non-CF bronchiectasis patients. Eur Respir J 2010; 36: Suppl. 54, 2904
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Paratracheal air cysts in patients with non-CF bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Ematic gases,bronchial obstruction and RV increase in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 328s
Year: 2004
Accompanying asthma in cystic fibrosis (CF) and non-CF bronchiectatic patients: could we detect it with AMP bronchoprovocation and sputum properties?
Source: Eur Respir J 2007; 30: Suppl. 51, 374s
Year: 2007
Dynamic bronchial obstruction in pulmonary sarcoidosis - study on 52 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002
Reversibility of airway obstruction in sarcoidosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 276s
Year: 2003
Changes in the lower airway bacterial community of from adult non-CF bronchiectasis population are significantly associated with exacerbations and the presence of
Heamophilus influenza
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Spontaneous airway obstruction masks FeNO level in patients with asthma but not COPD
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Infection and bronchial obstruction in COPD exacerbation
Source: Eur Respir J 2003; 22: Suppl. 45, 417s
Year: 2003
Significance of persistent airflow obstruction in patients with severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 406s
Year: 2002
Significance of small airway obstruction in patients with idiopathic pulmonary fibrosis.
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
CAPTAIN: Improvements in airflow obstruction in patients with uncontrolled asthma
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Proximal and peripheral airway morphologic changes in elderly patients with asthma with fixed airflow obstruction and COPD
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Co-morbidities are not associated with severity of airflow obstruction as measured by ATS/ERS/GOLD in patients with COPD
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008
Sustained maximum inspiratory pressure in patients with cystic fibrosis and severe airway obstruction
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001
What defines airflow obstruction in asthma?
Source: Eur Respir J 2009; 34: 568
Year: 2009
Rate of change of FEV
1
and VC in adults with chronic airflow obstruction
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015
The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept